TEST MEDIA AND QUANTITATIVE OR QUALITATIVE METHOD FOR IDENTIFICATION AND DIFFERENTIATION OF BIOLOGICAL MATERIALS IN A TEST SAMPLE
    3.
    发明公开
    TEST MEDIA AND QUANTITATIVE OR QUALITATIVE METHOD FOR IDENTIFICATION AND DIFFERENTIATION OF BIOLOGICAL MATERIALS IN A TEST SAMPLE 有权
    试验介质和定量或 定性方法识别和生物材料分化的测试样品

    公开(公告)号:EP1776465A2

    公开(公告)日:2007-04-25

    申请号:EP05765940.1

    申请日:2005-06-08

    IPC分类号: C12Q1/04

    摘要: A test medium and method for detecting, quantifying, identifying and differentiating up to four (4) separate biological materials in a test sample. A test medium is disclosed which allows quantifying and differentiating under ambient light aggregates of biological entities producing specific enzymes, which might include general coliforms, E. coli, Aeromonas, and Salmonella in a single test medium. A new class of nonchromogenic substrates is disclosed which produce a substantially black, non-diffusible precipitate. This precipitate is not subject to interference from other chromogenic substrates present in the test medium.; In one embodiment, the substrates are selected such that E. coli colonies present in the test medium show as substantially black, general coliforms colonies show in the test medium as a blue-violet color, Aeromonas colonies present in the test medium show as a generally red-pink color, and Salmonella colonies show as a generally teal-green color. Other microorganisms and color possibilities for detection and quantification thereof are also disclosed. An inhibitor and method for making a test medium incorporating the inhibitor are disclosed.

    A compound and a composition for therapeutic or diagnostic use
    4.
    发明授权
    A compound and a composition for therapeutic or diagnostic use 失效
    化合物和组合物用于治疗或诊断应用。

    公开(公告)号:EP0132242B1

    公开(公告)日:1993-10-27

    申请号:EP84850212.6

    申请日:1984-07-04

    申请人: SYMBICOM AB

    IPC分类号: A61K31/70 C12Q1/04

    摘要: A composition for therapeutic or diagnostic use in connection with the toxine of Shigella dysenteriae. As an active constituent the composition contains or consists of a compound having the formula (I): (I) wherein R1 is hydrogen or an organic residue, and R2 is hydrogen, alkyl, alkoxi or a carbohydric residue with the proviso that R2 is not beta -D-GalNacp-(1-0) when R1 is D-Glc or - beta -D-Glcp-(1-0)-ceramide and that R2 is different from OH, alpha -D-GalNAcp-(1-3)- beta -D-GalNAcp-(1-0)-, beta -D-GalNAcp-(1-3)- beta -D-GalNAcp-(-0)-, alpha -L-Fucp-(1-2)- beta -D-Galp-(1-3)- beta -D-GalNAcp-(1-0)- and alpha -L-Fucp-(1-2)- alpha -D-Galp-(1-3)-(1-0)-; a method for therapeutic treatment; and the use of the composition for therapeutic treatment or diagnosis.

    TEST MEDIA AND METHOD FOR IDENTIFICATION AND DIFFERENTIATION OF BACTERIA
    6.
    发明授权
    TEST MEDIA AND METHOD FOR IDENTIFICATION AND DIFFERENTIATION OF BACTERIA 有权
    试验介质和方法识别和细菌分化

    公开(公告)号:EP1874951B1

    公开(公告)日:2011-11-16

    申请号:EP06748499.8

    申请日:2006-03-21

    IPC分类号: C12Q1/04

    摘要: A test medium and method for detecting, quantifying, identifying and differentiating up to four (4) separate biological materials in a test sample. A test medium is disclosed which allows quantifying and differentiating under ambient light aggregates of biological entities producing specific enzymes, which might include general coliforms, E. coli, Aeromonas, and Salmonella in a single test medium. A new class of nonchromogenic substrates is disclosed which produce a substantially black, non-diffusible precipitate. This precipitate is not subject to interference from other chromogenic substrates present in the test medium. In one embodiment, the substrates are selected such that E. coli colonies present in the test medium show as substantially black, general coliforms colonies show in the test medium as a blue-violet color, Aeromonas colonies present in the test medium show as a generally red-pink color, and Salmonella colonies show as a generally teal-green color. Other microorganisms and color possibilities for detection and quantification thereof are also disclosed. An inhibitor and method for making a test medium incorporating the inhibitor are disclosed.

    TEST MEDIA AND QUANTITATIVE OR QUALITATIVE METHOD FOR IDENTIFICATION AND DIFFERENTIATION OF BIOLOGICAL MATERIALS IN A TEST SAMPLE

    公开(公告)号:EP1874951A1

    公开(公告)日:2008-01-09

    申请号:EP06748499.8

    申请日:2006-03-21

    IPC分类号: C12Q1/04

    摘要: A test medium and method for detecting, quantifying, identifying and differentiating up to four (4) separate biological materials in a test sample. A test medium is disclosed which allows quantifying and differentiating under ambient light aggregates of biological entities producing specific enzymes, which might include general coliforms, E. coli, Aeromonas, and Salmonella in a single test medium. A new class of nonchromogenic substrates is disclosed which produce a substantially black, non-diffusible precipitate. This precipitate is not subject to interference from other chromogenic substrates present in the test medium. In one embodiment, the substrates are selected such that E. coli colonies present in the test medium show as substantially black, general coliforms colonies show in the test medium as a blue-violet color, Aeromonas colonies present in the test medium show as a generally red-pink color, and Salmonella colonies show as a generally teal-green color. Other microorganisms and color possibilities for detection and quantification thereof are also disclosed. An inhibitor and method for making a test medium incorporating the inhibitor are disclosed.

    ANTIBODY TO CYTOLETHAL DISTENDING TOXIN OF CAMPYLOBACTER JEJUNI
    10.
    发明公开
    ANTIBODY TO CYTOLETHAL DISTENDING TOXIN OF CAMPYLOBACTER JEJUNI 有权
    抗菌素GEGEN CYTOLETHAL抑制毒素VON CAMPYLOBACTER JEJUNI

    公开(公告)号:EP2396652A4

    公开(公告)日:2014-11-19

    申请号:EP10741728

    申请日:2010-02-11

    IPC分类号: G01N33/48 C07K16/00

    摘要: Methods for preventing IBS, reducing the likelihood of developing IBS and/or treating IBS by administering COT inhibitors and/or COT neutralizers to a subject in need thereof are described. Methods of eliciting a specific immune response and methods of vaccinating a subject to prevent IBS or to reduce the likelihood of developing or having IBS are also provided. Methods of diagnosing IBS by detecting the presence or absence of COT or a COT marker in a subject are described.

    摘要翻译: 描述了通过向有需要的受试者施用COT抑制剂和/或COT中和剂来预防IBS,降低发展IBS和/或治疗IBS的可能性的方法。 还提供了引发特异性免疫应答的方法和接种受试者的方法以防止IBS或降低发展或具有IBS的可能性。 描述了通过检测受试者中COT或COT标记物的存在或不存在来诊断IBS的方法。